波士顿科学

US · BSX #364 按市值排名上市于 1970

44.39 +0.25 +0.57%

实时 - 追踪5344个代码 - 心跳于457秒前 · 2026-10-16 20:02

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了13家。
机构持股总比例下降了0.2个百分点。

机构持股

机构持股比例: 93.99% -0.16pp
机构数量: 1,845 -13
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund72.99%

Hedge Fund8.54%

Public Company3.52%

Government Pension Fund3.03%

Private Company2.89%

Sovereign Wealth Fund1.54%

VC/PE Fund0.56%

Corporate Pension Plan0.35%

Insurance Company0.21%

Other6.36%

主要股东截至 2026-06-30

BlackRock 8.95% · 129.68M 股

Vanguard Capital Management, LLC 7.28% · 105.43M 股

State Street Global Advisors 4.84% · 70.11M 股

PRIMECAP Management Company 3.49% · 50.52M 股

FMR 2.73% · 39.53M 股

Other 72.73%

Geode Capital Management, LLC 2.31% · 33.44M 股

Capital Research 2.17% · 31.49M 股

Vanguard Portfolio Management, LLC 2.06% · 29.79M 股

UBS Asset Management 2.03% · 29.44M 股

D. E. Shaw & Co., L.P. 1.76% · 25.46M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 38次买入 · 11次卖出

姓名	职务	持股比例
Michael Mahoney	Chairperson & CEO	0.11%
Joseph Fitzgerald	Executive VP & Group President of Cardiology	0.02%
Daniel Brennan	Chief Financial Officer	0.01%
Arthur Crosswell Butcher	Executive VP and Group President of MedSurg & Asia Pacific	0.01%
Jeffrey Mirviss	Executive VP & President of Peripheral Interventions	0.00%
Charles Dockendorff	Independent Director	0.00%
John Sununu	Independent Director	0.00%
Vance Brown	Senior Vice President	0.00%
Jonathan Monson	Senior VP, Global Controller & Chief Accounting Officer	0.00%
David Wichmann	Independent Director	0.00%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-01	Padraig O'Connor	--	Derivative Exercise and Sale	-567	$48.37
2026-09-01	Padraig O'Connor	--	Derivative Exercise and Retained	+604	--
2026-08-24	Susan Morano	Director	Open Market Acquisition	+2,040	$49.22
2026-08-10	Emily Woodworth	Senior VP, Global Controller & Chief Accounting Officer	Acquisition Under Employee Benef	+2,930	$51.19
2026-08-09	Jonathan Monson	Senior VP, Global Controller & Chief Accounting Officer	Acquisition Under Employee Benef	+9,908	$50.46
2026-08-04	David Habiger	Director	Open Market Acquisition	+2,100	$47.59
2026-08-03	David Habiger	Director	Open Market Acquisition	+1,182	$48.07–48.59
2026-08-02	Michael Mahoney	Chairperson & CEO	Open Market Acquisition	+186,240	$48.33
2026-08-02	Michael Mahoney	Chairperson & CEO	Acquisition Under Employee Benef	+22,119	$48.43
2026-07-30	Edward Ludwig	Lead Independent Director	Open Market Acquisition	+5,000	$45.48
2026-07-30	Joseph Fitzgerald	Executive VP & Group President of Cardiology	Acquisition Under Employee Benef	+64,198	$46.73
2026-06-30	Jonathan Monson	Senior VP, Global Controller & Chief Accounting Officer	Derivative Exercise and Sale	-1,010	$43.06
2026-06-30	Jonathan Monson	Senior VP, Global Controller & Chief Accounting Officer	Derivative Exercise and Retained	+1,077	--
2026-05-27	Michael Mahoney	Chairperson & CEO	Other Disposition	-386,755	--
2026-05-19	Edward Ludwig	Lead Independent Director	Open Market Acquisition	+3,580	$56.68
2026-05-19	Cheryl Pegus	Director	Open Market Acquisition	+1,770	$56.49
2026-05-19	David Habiger	Director	Open Market Acquisition	+4,450	$55.92–56.95
2026-05-06	Edward Ludwig	Lead Independent Director	Other Acquisition	+3,800	--
2026-05-06	Ellen Zane	Independent Director	Other Acquisition	+3,800	--
2026-05-06	David Wichmann	Independent Director	Other Acquisition	+3,800	--

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:14 · 仅供参考，不构成投资建议，也未考虑您的具体情况。